Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 160,2x - 177,1x | 168,7x |
| Selected Fwd EBIT Multiple | 8,3x - 9,2x | 8,7x |
| Fair Value | ₩317,80 - ₩368,43 | ₩343,12 |
| Upside | -52,6% - -45,1% | -48,9% |
| Benchmarks | Ticker | Full Ticker |
| Cell Bio Human Tech Co.,Ltd | A318160 | KOSDAQ:A318160 |
| S&K Polytec Co., Ltd. | A091340 | KOSDAQ:A091340 |
| Kumyang Co., Ltd. | A001570 | KOSE:A001570 |
| Chemtros Co., Ltd. | A220260 | KOSDAQ:A220260 |
| ENBIO Co., Ltd. | A352940 | KOSDAQ:A352940 |
| Nano Chem Tech Inc. | A091970 | KOSDAQ:A091970 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A318160 | A091340 | A001570 | A220260 | A352940 | A091970 | ||
| KOSDAQ:A318160 | KOSDAQ:A091340 | KOSE:A001570 | KOSDAQ:A220260 | KOSDAQ:A352940 | KOSDAQ:A091970 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -3.1% | -9.9% | NM- | 8.0% | -20.9% | -50.8% | |
| 3Y CAGR | -10.4% | 31.2% | NM- | -0.4% | 7.1% | NM- | |
| Latest Twelve Months | 28.2% | 99.7% | -67.1% | -62.2% | 116.0% | 102.5% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 12.6% | 2.1% | -5.6% | 6.7% | -1.3% | -9.1% | |
| Prior Fiscal Year | 11.5% | 1.1% | -11.2% | 7.2% | -9.9% | -3.9% | |
| Latest Fiscal Year | 14.2% | 4.6% | -36.6% | 7.5% | 3.9% | 0.3% | |
| Latest Twelve Months | 14.2% | 5.1% | -34.6% | 4.0% | 3.5% | 0.1% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.39x | 0.22x | 5.86x | 2.36x | 1.27x | 0.69x | |
| EV / LTM EBITDA | 6.6x | 3.1x | -26.9x | 19.2x | 15.6x | 16.3x | |
| EV / LTM EBIT | 9.8x | 4.4x | -16.9x | 58.3x | 36.3x | 696.9x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -16.9x | 9.8x | 58.3x | ||||
| Historical EV / LTM EBIT | -34.5x | -21.0x | -2.7x | ||||
| Selected EV / LTM EBIT | 160.2x | 168.7x | 177.1x | ||||
| (x) LTM EBIT | 52 | 52 | 52 | ||||
| (=) Implied Enterprise Value | 8,288 | 8,724 | 9,160 | ||||
| (-) Non-shareholder Claims * | (11,792) | (11,792) | (11,792) | ||||
| (=) Equity Value | 0 | 0 | 0 | ||||
| (/) Shares Outstanding | 36.1 | 36.1 | 36.1 | ||||
| Implied Value Range | 0.00 | 0.00 | 0.00 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.00 | 0.00 | 0.00 | 671.00 | |||
| Upside / (Downside) | -100.0% | -100.0% | -100.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A318160 | A091340 | A001570 | A220260 | A352940 | A091970 | |
| Enterprise Value | 39,402 | 74,163 | 886,107 | 112,087 | 43,055 | 36,042 | |
| (+) Cash & Short Term Investments | 14,306 | 72,382 | 22,226 | 29,355 | 2,677 | 4,999 | |
| (+) Investments & Other | 1,034 | 7,484 | 42,613 | 696 | 1,951 | 11,420 | |
| (-) Debt | (4,068) | (80,772) | (314,943) | (24,352) | (19,427) | (28,179) | |
| (-) Other Liabilities | 0 | (44,020) | (3,962) | 0 | 0 | (33) | |
| (-) Preferred Stock | (447) | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 50,228 | 29,236 | 632,041 | 117,786 | 28,256 | 24,250 | |
| (/) Shares Outstanding | 8.3 | 10.7 | 63.8 | 26.6 | 10.9 | 36.1 | |
| Implied Stock Price | 6,040.00 | 2,730.00 | 9,900.00 | 4,435.00 | 2,600.00 | 671.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 6,040.00 | 2,730.00 | 9,900.00 | 4,435.00 | 2,600.00 | 671.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |